RE
HURA

RBC Europe’s TuHURA Biosciences HURA Stock Holding History

RBC Europe’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-22
Closed -$32.4K – 1185
2021
Q3 		$32.4K Hold
22
– – ﹤0.01% 673
2021
Q2 		$85.5K Hold
22
– – ﹤0.01% 466
2021
Q1 		$65.5K Hold
22
– – ﹤0.01% 494
2020
Q4 		$48.2K Buy
22
+5
+29% +$12.5K ﹤0.01% 527
2020
Q3 		$42K Hold
17
– – ﹤0.01% 499
2020
Q2 		$20.6K Hold
17
– – ﹤0.01% 624
2020
Q1 		$11.9K Hold
17
– – ﹤0.01% 663
2019
Q4 		$20.7K Buy
+17
New +$18.3K ﹤0.01% 642

Other funds holding HURA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
S
swisspartners Vaduz, Liechtenstein $78.4M AUM 9.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

RBC Europe's HURA Position: Q4 2021 in Review

RBC Europe sold out of TuHURA Biosciences (HURA) in Q4 2021, closing a stake of 22 shares — an estimated $32.4K sold.

RBC Europe first reported a position in HURA in Q4 2019 and held it in 8 quarters. The position peaked at $85.5K in Q2 2021. 24 funds tracked by Wall St. Rank hold HURA as of Q4 2021.

  • RBC Europe reported no remaining TuHURA Biosciences position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 22 TuHURA Biosciences shares in Q4 2021, an estimated $32.4K.
  • RBC Europe first reported a position in TuHURA Biosciences in Q4 2019 and held it in 8 quarters.
  • RBC Europe's TuHURA Biosciences position peaked at $85.5K in Q2 2021.
  • 24 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.